更正：Møller, P. 等人。常见致病变异的原因包括生育年龄的低外显率、反复出现的新发突变和遗传漂变。2019年， ，132。
Correction: Møller, P.; et al. Causes for Frequent Pathogenic Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift. 2019, , 132.
作者信息
Møller Pål, Dominguez-Valentin Mev, Rødland Einar Andreas, Hovig Eivind
机构信息
Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Part of Oslo University Hospital, 0424 Oslo, Norway.
Center for Hereditary Tumors, HELIOS-Klinikum Wuppertal, University ofWitten-Herdecke, 42283 Wuppertal, Germany.
出版信息
Cancers (Basel). 2020 Feb 10;12(2):410. doi: 10.3390/cancers12020410.
Abstract
The authors wish to make the following corrections to this paper [1]: The authors would like to replace Table 3 in [1]. The corrections are correcting typographical errors when translating our database in BIC format to HGVS nomenclature, and removing four carriers which had zero follow-up time. [...].
摘要
作者希望对本文[1]做出以下更正：作者想要替换[1]中的表3。更正是在将我们的BIC格式数据库转换为HGVS命名法时纠正排版错误，并删除四个随访时间为零的携带者。[……]
相似文献
1
Correction: Møller, P.; et al. Causes for Frequent Pathogenic Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift. 2019, , 132.更正：Møller, P. 等人。常见致病变异的原因包括生育年龄的低外显率、反复出现的新发突变和遗传漂变。2019年， ，132。
Cancers (Basel). 2020 Feb 10;12(2):410. doi: 10.3390/cancers12020410.
2
Causes for Frequent Pathogenic Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift.频繁出现致病变异的原因包括生育年龄的低外显率、反复的新生突变和遗传漂变。
Cancers (Basel). 2019 Jan 23;11(2):132. doi: 10.3390/cancers11020132.
3
Double heterozygous mutation in the BRCA1 and ATM genes involved in development of primary metachronous tumours: a case report.BRCA1 和 ATM 基因双重杂合突变与原发性异时性肿瘤的发生相关：病例报告。
Breast Cancer Res Treat. 2019 Oct;177(3):767-770. doi: 10.1007/s10549-019-05343-4. Epub 2019 Jul 10.
4
Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.与波兰人群乳腺癌风险增加相关的BRCA1和BRCA2基因结构改变的分子诊断的选定方面
Hered Cancer Clin Pract. 2006 Aug 15;4(3):142-52. doi: 10.1186/1897-4287-4-3-142.
5
Common genetic variants contribute to incomplete penetrance: evidence from cancer-free BRCA1 mutation carriers.常见的遗传变异导致不完全外显：来自无癌症 BRCA1 突变携带者的证据。
Eur J Cancer. 2019 Jan;107:68-78. doi: 10.1016/j.ejca.2018.10.022. Epub 2018 Dec 11.
6
Correction: Alfat et al. Phase Field Models for Thermal Fracturing and Their Variational Structures. 2022, , 2571.更正：阿尔法特等人。热压裂的相场模型及其变分结构。2022年，，2571。
Materials (Basel). 2022 May 19;15(10):3623. doi: 10.3390/ma15103623.
7
Clinical Implementation and Validation of Automated Human Genome Variation Society (HGVS) Nomenclature System for Next-Generation Sequencing-Based Assays for Cancer.临床实施和验证基于下一代测序的癌症检测的自动化人类基因组变异协会 (HGVS) 命名系统。
J Mol Diagn. 2018 Sep;20(5):628-634. doi: 10.1016/j.jmoldx.2018.05.006. Epub 2018 Jun 21.
8
Clinical impact of unclassified variants of the BRCA1 and BRCA2 genes.BRCA1 和 BRCA2 基因未分类变异的临床影响。
J Med Genet. 2011 Nov;48(11):783-6. doi: 10.1136/jmedgenet-2011-100305. Epub 2011 Oct 1.
9
BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations.BRCA1基因的1675delA和1135insA突变占挪威家族性乳腺癌-卵巢癌的三分之一，且与较罕见突变相比，这些突变与疾病发病较晚有关。
Dis Markers. 1999 Oct;15(1-3):79-84. doi: 10.1155/1999/278269.
10
Correction: Rasmussen, B.B., et al. Global and phylogenetic distribution of quorum sensing signals, acyl homoserine lactones, in the family of vibrionaceae. Mar. Drugs 2014, 12, 5527-5546.更正：拉斯穆森，B.B. 等人。群体感应信号——酰基高丝氨酸内酯在弧菌科中的全球分布和系统发育分布。《海洋药物》2014年，第12卷，第5527 - 5546页。
Mar Drugs. 2015 Mar 20;13(3):1548-51. doi: 10.3390/md13031548.
引用本文的文献
1
BRCA1 Norway: comparison of classification for BRCA1 germline variants detected in families with suspected hereditary breast and ovarian cancer between different laboratories.BRCA1 挪威：对不同实验室在疑似遗传性乳腺癌和卵巢癌家族中检测到的 BRCA1 种系变异进行分类的比较。
Fam Cancer. 2022 Oct;21(4):389-398. doi: 10.1007/s10689-021-00286-6. Epub 2022 Jan 4.
本文引用的文献
1
Causes for Frequent Pathogenic Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift.频繁出现致病变异的原因包括生育年龄的低外显率、反复的新生突变和遗传漂变。
Cancers (Basel). 2019 Jan 23;11(2):132. doi: 10.3390/cancers11020132.
Zotero 插件